K081641

Substantially Equivalent

COULTER LIN-X LINEARITY CONTROL

Applicant: Beckman Coulter, Inc.
Product code: JPK
Advisory panel: Hematology
Date received: 2008-06-11
Decision date: 2009-01-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.